Very positive signs with low volume no less? Sum i
Post# of 582
recognizing an undervalued oversold equity that is soon to receive an uplisting to the OTC? CEO Brian Thom appears to be delivering! Uplisting + FDA IDE approval for the clinical research and bua-lah .20+

